None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: ? Adults aged 18 or older ? Patients who have been newly diagnosed with lung cancer and are scheduled for lung resection surgery
Exclusion criteria
Exclusion criteria: ? Patients who are pregnant or breastfeeding ? Patients taking anti-inflammatory painkillers due to chronic inflammatory diseases ? Patients taking immunosuppressants, anticancer drugs, steroids, or antibiotics (with a history of use within 60 days prior to the scheduled date of the first stool collection kit) ? Patients taking antiplatelet or anticoagulant medications ? Patients with chronic renal failure ? Patients with a history of taking turmeric extract complexes ? Patients scheduled for lobectomy or total pneumonectomy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Investigate changes in the gut microbiome according to the administration of a turmeric extract complex before and after lung cancer surgery through 16S rRNA gene sequencing data analysis, and compare the difference between the two groups by measuring fatigue scores using an interval rating scale. | — |
Secondary
| Measure | Time frame |
|---|---|
| Compare the differences between the two groups by measuring postoperative pain depending on whether turmeric extract is administered or not during the pre- and post-operative process of lung cancer;Compare the differences between the two groups by measuring the effect of reducing inflammation depending on whether turmeric extract is administered or not during lung cancer surgery;Compare the differences between the two groups by measuring physical activity depending on whether turmeric extract is administered or not during lung cancer surgery;The difference between the two groups was compared by measuring the quality of life according to whether turmeric extract was administered or not during the pre- and post-operative procedure for lung cancer | — |
Countries
Korea, Republic of
Contacts
Samsung Medical Center